This is an observational study: This is an observational study
Study summary
This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Patients pathologically confirmed with colon cancer via endoscopic biopsy.
2. Patients who underwent preoperative abdominopelvic enhanced spectral CT.
3. Study participant with age ≥ 18 years old.
4. Study participants that have signed Informed Consent Form (ICF).
Exclusion Criteria:
1. The clinical data or pathological information is considered incomplete after evaluation by the investigator.
2. The investigator determined that poor image quality (e.g. obvious artifacts, missing critical scan layers) would not satisfy post-processing analysis.
3. Data of patients deemed inappropriate for inclusion after evaluation by the investigator.
Primary outcome measure(s)
subjective overall Image quality using 5-point Likert scale(1-5) — From the date of image reconstruction completion to the date of image evaluation completion, anticipated 3 Months. Radiologist will evaluate the overall image quality using 5 Likert scale ranging from 1(poor) to 5 (Excellent)
Objective image quality — From the date reconstruction completion to the date of image evaluation completion, anticipated 3months. The objective image quality is evaluated by measuring the CT value shown in the image.
Trial sites (1)
Facility
City
Region
Status
Sun Yat-sen cancer center
Guangzhou
Guangdong
More Philips Clinical & Medical Affairs Global trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.